The global antifungal drugs market had a value of USD 11.93 Billion in 2020 and is projected to achieve a revenue CAGR of 1.4% during the forecast period. The market's revenue growth is primarily driven by key factors such as the increasing incidence of mucormycosis, candidiasis, dermatophytosis, and aspergillosis across all age groups worldwide. Additionally, the growing awareness about fungal...